carbostyril has been researched along with Diabetic Neuropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Borea, PA; Corciulo, C; Gessi, S; Merighi, S; Saponaro, G; Tabrizi, MA; Targa, M; Varani, K; Vincenzi, F | 1 |
| Arora, M; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
| Kumar, A; Negi, G; Sharma, SS | 1 |
| Kaundal, RK; Kumar, A; Sharma, SS | 1 |
| Holmes, PR; Mayer, JH; Tomlinson, DR | 1 |
| Mayer, JH; Tomlinson, DR | 1 |
6 other study(ies) available for carbostyril and Diabetic Neuropathies
| Article | Year |
|---|---|
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
Topics: Animals; Behavior, Animal; Chronic Pain; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Ganglia, Spinal; Humans; Hyperalgesia; Inflammation; Male; Mice; Motor Activity; Musculoskeletal Pain; NF-kappa B; Oxazines; Pain Measurement; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Treatment Outcome | 2013 |
Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Topics: 1-Naphthylamine; Animals; Antioxidants; Diabetic Neuropathies; Male; Malondialdehyde; NAD; Naphthalimides; Neural Conduction; Neuralgia; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Quinolones; Rats; Rats, Sprague-Dawley; Resveratrol; Sciatic Nerve; Stilbenes | 2009 |
Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; DNA Damage; Male; Metalloporphyrins; Naphthalimides; Oxidative Stress; Peripheral Nerves; Peroxynitrous Acid; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Rats; Rats, Sprague-Dawley | 2010 |
Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Humans; Male; NAD; Naphthalimides; Neural Conduction; Pain Measurement; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Rats; Rats, Sprague-Dawley; Streptozocin | 2008 |
Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.
Topics: Aldehyde Reductase; Animals; Axonal Transport; Choline O-Acetyltransferase; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Neurons; Neural Conduction; Quinolines; Quinolones; Rats | 1982 |
Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Topics: Aldehyde Reductase; Animals; Axonal Transport; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Inositol; Male; Motor Neurons; Neural Conduction; Quinolines; Quinolones; Rats; Rats, Inbred Strains; Sciatic Nerve; Sorbitol; Streptozocin; Sugar Alcohol Dehydrogenases | 1983 |